Cipla Q4 preview: Robust domestic traction, gRevlimid sales likely to give earnings a big boost
Cipla Q4 preview: The company is expected to double its consolidated net profit to Rs 723.4 crore from Rs 362.07 crore in the year-ago quarter. It is also seen as the biggest beneficiary of a strong flu season in India